C07D 503/10
Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a
Official title: with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
C07D503/10 (Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C07D- Granted patents
- 3
- Published applications
- 5
- Assignees
- 6
- Inventors
- 13
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Beta-lactam compounds and methods of use thereof12 May 2026US 12,624,382 B2The University of Hong Kong
- Lactivicin compounds, their preparation and use as antibacterial agents10 Oct 2023US 11,780,832 B2Fedora Pharmaceuticals Inc.
- Regulation of nitric oxide release and biofilm development13 Oct 2015US 9,156,855 B2Newsouth Innovation Pty Limited
- Mercaptoacetophenone aminohydrazones, their salts and uses thereof21 Nov 2024US 2024/0383846 A1London Pharmaceuticals and Research Corporation
- Lactivicin compounds, their preparation and use as antibacterial agents13 Oct 2022US 2022/0324858 A1Fedora Pharmaceuticals Inc.
- Beta-lactam compounds and methods of use thereof8 Jul 2021US 2021/0207188 A1The University of Hong Kong
- Regulation of nitric oxide release and biofilm development14 Jan 2016US 2016/0009733 A1NewSouth Innovations Pty Limited
- Regulation of nitric oxide release and biofilm development7 Aug 2014US 2014/0221331 A1NewSouth Innovations Pty Limited
Most cited
By later US patents